Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 3
1974 2
1976 2
1977 1
1978 1
1979 2
1986 8
1990 1
1991 1
1992 2
1994 2
1995 4
1996 7
1997 12
1998 13
1999 13
2000 2
2001 8
2002 12
2003 12
2004 8
2005 17
2006 11
2007 13
2008 19
2009 21
2010 10
2011 11
2012 9
2013 3
2014 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Wen PY, et al. Among authors: lamborn kr. J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231676
Gliomatosis cerebri: a review of 22 cases.
Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. Vates GE, et al. Among authors: lamborn kr. Neurosurgery. 2003 Aug;53(2):261-71; discussion 271. doi: 10.1227/01.neu.0000073527.20655.e6. Neurosurgery. 2003. PMID: 12925240 Review.
Clinical trial end points for high-grade glioma: the evolving landscape.
Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. Reardon DA, et al. Among authors: lamborn kr. Neuro Oncol. 2011 Mar;13(3):353-61. doi: 10.1093/neuonc/noq203. Epub 2011 Feb 9. Neuro Oncol. 2011. PMID: 21310734 Free PMC article. Review.
In reference to lamborn et Al. (Neuro-oncology. 2008;10:162-170).
Meyers CA, Lamborn KR, Prados MD. Meyers CA, et al. Among authors: lamborn kr. Neuro Oncol. 2008 Dec;10(6):1171-2. doi: 10.1215/15228517-2008-055. Epub 2008 Aug 25. Neuro Oncol. 2008. PMID: 18725461 Free PMC article. No abstract available.
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY; Response Assessment in Neuro-Oncology (RANO) group. Lin NU, et al. Among authors: lamborn kr. Lancet Oncol. 2013 Sep;14(10):e396-406. doi: 10.1016/S1470-2045(13)70311-5. Lancet Oncol. 2013. PMID: 23993384 Review.
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD; North American Brain Tumor Consortium. Chang SM, et al. Among authors: lamborn kr. Neuro Oncol. 2008 Aug;10(4):631-42. doi: 10.1215/15228517-2008-021. Epub 2008 Jun 17. Neuro Oncol. 2008. PMID: 18559968 Free PMC article. Review.
Second cancers following pediatric Hodgkin's disease.
Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. Wolden SL, et al. Among authors: lamborn kr. J Clin Oncol. 1998 Feb;16(2):536-44. doi: 10.1200/JCO.1998.16.2.536. J Clin Oncol. 1998. PMID: 9469338
214 results